Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

kaposiform hemangioendothelioma News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study highlights the high responsiveness of head and neck kaposiform hemangioendothelioma to sirolimus monotherapy, particularly in cases without the Kasabach-Merritt phenomenon. This finding could inform treatment strategies for this rare vascular tumor.

A recent study reports spontaneous regression of kaposiform hemangioendothelioma without the associated Kasabach-Merritt phenomenon. This finding may provide new insights into the natural history and management of this rare vascular tumor.

Not rare diseases news,news about your rare disease.

Earlier

A recent study highlights the high responsiveness of head and neck kaposiform hemangioendothelioma to sirolimus monotherapy, particularly in cases without the Kasabach-Merritt phenomenon. This finding could inform treatment strategies for this rare vascular tumor.

A recent study reports spontaneous regression of kaposiform hemangioendothelioma without the associated Kasabach-Merritt phenomenon. This finding may provide new insights into the natural history and management of this rare vascular tumor.

Not rare diseases news,
news about your rare disease.